In basal-like tumours in vivo, however, the exact opposite seems to occur in that the RB-pathway barrier appears to be RB1 functional loss with a concomitant feedback loop that induces p16INK4a gene and protein expression. The gene discussed is RB1; the disease is neoplasm.